Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 30 - Oct 5
10.1038/nrneurol.2010.127 Nat
As a public-benefit corporation (PBC), our social mission of improving public health is just as important as the bottom line
This is the practical question most patients care about
Lilly Launches Trulicity in the US First Ever Ready-to-Use Once-Weekly GLP-1 Receptor Agonist Twitter summary: @LillyDiabetes launches Trulicity in the US first ready-to-use once-weekly GLP-1, available w/savings program for commercially insured On November 10, Eli Lilly and company announced that Trulicity (dulaglutide) is now available in the US, making it the first ready-to-use once weekly GLP-1 receptor agonist to reach the market (no mixing required)
US$ 23.85
US$ 26.71
US$ 21.72
